The Cutaneous Connection
Claim This Podcastby The Cutaneous Connection
Podcast Overview
<div>From the latest updates in dermatology to exclusive interviews with leading industry experts and a glimpse at what goes on behind the scenes, the staff at Dermatology Times brings you a podcast that will explore the impact of new data and support you in implementing innovative technologies that advance your patient care and practice. Join us under the dermatoscope for The Cutaneous Connection. </div>
Language
🇺🇲
Publishing Since
6/24/2020
2 verified contact emails on file for The Cutaneous Connection
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 7, 2026
S2 Ep24: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment
<div> <p>In this episode of The Cutaneous Connection, Dermatology Times revisits a recent video episode of the Derm Dispatch show where host Renata Block, DMSc, MMS, PA-C, sits down with Zachary Rubin, MD — allergist, pediatrician, and New York Times bestselling author of All About Allergies — to explore the intersection of dermatology and allergy. Together, they tackle one of the most persistent myths in practice: that food elimination can treat atopic dermatitis. </p><p>Dr. Rubin breaks down the difference between IgE-mediated allergic reactions and the complex inflammatory nature of eczema, explains the atopic march, and discusses how understanding the gut-lung-skin axis can empower patients to take charge of their care. The conversation also covers the latest treatment advances — from JAK inhibitors to novel biologics — and touches on indolent systemic mastocytosis and the truth about so-called hypoallergenic dogs. A must-listen for any clinician treating allergic and inflammatory skin disease.</p><p>For more content, visit <a href="https://www.dermatologytimes.com/">https://www.dermatologytimes.com/</a></p></div>
May 1, 2026
S2 Ep23: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis
<div> <p>Join Dermatology Times for a conversation with Liza O'Dowd, MD, vice president of immunodermatology and respiratory disease areas at Johnson & Johnson, recorded at the 2026 AAD Annual Meeting. Dr. O'Dowd discusses one-year efficacy and safety data for icotrokinra (Icotyde), the newly approved once-daily oral peptide IL-23 receptor antagonist for moderate to severe plaque psoriasis in adults and adolescents 12 and older. </p><p>At 52 weeks, approximately 50% of adult patients achieved total skin clearance, rising to 60% in adolescents enrolled in the LEAD study. Adverse event rates through one year remained within 1.1% of placebo, with no mandatory tuberculosis pre-screening required. Dr. O'Dowd also addresses icotrokinra's anticipated role as a first-line systemic therapy and offers practical reassurance for clinicians considering this novel agent for their patients.</p><p>For more content from Dermatology Times, visit <a href="https://www.dermatologytimes.com/">https://www.dermatologytimes.com/</a></p></div>
April 9, 2026
S2 Ep22: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?
<div><p>In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS. </p></div>
79 total episodes available
Recent guests on The Cutaneous Connection
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Itisha S. Jefferson
Guest
Amy Paller MD
Guest
Albert Yan MD FAAP FAAD
Guest
James Song MD FAAD
Guest
Nanette Silverberg MD
Guest
Bradley Burnam
Guest
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for The Cutaneous Connection
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is The Cutaneous Connection?
<div>From the latest updates in dermatology to exclusive interviews with leading industry experts and a glimpse at what goes on behind the scenes, the staff at Dermatology Times brings you a podcast that will explore the impact of new data and support you in implementing innovative technologies that advance your patient care and practice. Join us under the dermatoscope for The Cutaneous Connection. </div> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.